FDA Announces Approval of Biologics Information Collection

Summary

The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) to collect information related to biologics licensing, labeling, and postmarketing studies, as outlined in the Paperwork Reduction Act of 1995.